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ABSTRACT 
 
 
Background: Although millions of lives are saved by blood transfusion, unsafe transfusion is also putting millions 
of people at risk of Transfusion Transmissible Infections (TTI). In Ethiopia the safety and magnitude of blood 
transfusion and TTIs is not well investigated. 
Objective: to investigate the magnitude of TTIs and assess TTI related risk factors among blood donors. 
Methods: Cross-sectional study among blood donors at the Red Cross Society Blood Bank in Gondar University 
Hospital, North West Ethiopia. 
Results: The study was conducted among 600 adult blood donors between April and July 2004. Their mean age 
was 28 +/- 10.4 years (range: 16-64) and 66% of them were urban dwellers. The donors included farmers 
(30.7%), daily laborers (22.7%) and students (20%). All the donors were first time donors and 75% of the dona-
tions were replacement donations by remunerated donors or family members. The prevalence of HIV, Hepatitis B 
surface antigen (HBSAg) and Hepatitis C virus (HCV) infections were 4.5% ( 95%CI: 3.0-6.6), 8.2% (95%CI: 6.2-
10.7) and 5.8% (95%CI: 4.2-8.1), respectively. The overall discard rate of donated blood because of these viral 
markers was 16.3%. In univariate analysis, HCV infection was significantly associated with presence of HIV (OR: 
5.36, 95%CI: 2-14.3). Experiences of traditional surgical incisions or phlebotomy were present in 93.8% of do-
nors. While 6.5% of donors admitted a history of multiple sexual partners, none of them admitted a history of any 
sexually transmitted infections (STI). 
Conclusion: The prevalence of TTIs among blood donors is very high. The majorities of blood donors are replace-
ment or paid donors with one or more of the risk factors for TTIs implying that blood transfusion is unsafe. These 
findings call for the urgent implementation of the national strategy for safe blood transfusion in Ethiopia. As the 
utilization of advanced technology and skilled-personnel-based screening of blood are not in the immediate hori-
zon, establishing stringent selection criteria of donors and setting clinical indications for transfusion would be 
indispensable and cost-effective interventions to minimize the risk of TTIs to blood recipients in Ethiopia. 
 
 INTRODUCTION 
 
 
Although millions of lives are saved from death by 
blood transfusion, many recipients are acquiring or 
are at risk of acquiring transfusion transmissible in-
fections (TTIs) due to provision of untested or poorly 
tested blood and poor blood donor recruitment and 
selection practices. A global study on blood safety 
conducted from 1998-99 in 175 countries by GDBS 
( WHO Global Database on Blood Safety) indicated 
that more than 40% of the donated blood in poor 
countries were not screened for TTIs and 80% of the 
world population had access to only 20% of the 
global supply of safe and screened blood (1). As a 
consequence, about 5-10% of HIV infections in de-
veloping countries are attributable to unsafe blood 
transfusion (2). This is very high compared to the 
chance of getting HIV infection through transfusion 
in the developed world, which is 1 out of 500,000 
transfusions (3). 
 
The blood transfusion service (BTS) in Ethiopia is 
not well coordinated by a national program. The 
Ethiopian Red Cross Society administers about 12 
Blood Banks in seven of the 11 regional states in the 
country, and more than 65% of the hospitals in the 
country do not have access to any BTS. About 60% 
of the blood donors in Addis Ababa and almost all of 
the donors in the rest of the country are family re-
placement donors. Recognizing the weaknesses of 
the existing BTS and the importance of safe transfu-
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 sion, the Federal Ministry of Health has recently 
launched a five year strategic plan in National Blood 
transfusion services with the objectives to establish a 
nationally coordinated BTS, to promote voluntary 
non-remunerated and regular blood donation, to im-
prove safety of blood, to promote appropriate and 
safe utilization of blood, and to establish a compre-
hensive quality management throughout the BTS (4). 
 
In Ethiopia there is a shortage of blood and unsafe 
transfusion is also common (4-6). The prevalence of 
TTIs among the general population in Ethiopia are 
very high. The national prevalence of HIV in Ethio-
pia is 4.4 % and urban prevalence is 12.6% (7). The 
prevalence of markers of Hepatitis B exposure and 
Hepatitis B surface Antigen (HBsAg) in the commu-
nity are more than 70% and 7-11%,  respectively 
(8,9). Considering such high rate of exposure and 
infection rates, some authorities recommended that 
indiscriminate screening of blood donors for HBsAg 
may not be warranted (10), and hence until recently 
screening of donated bloods for HBsAg was re-
stricted to blood to be administered to children and 
foreigners (5). The magnitude of HCV infection in 
the Ethiopian population is not well studied. From-
mel D and his colleagues reported that the prevalence 
of Anti-hepatitis C virus antibody (anti-HCV Ab) 
among urban and rural Ethiopian communities was 
2% (11).  In Addis Ababa, seroprevalence of HCV 
infection was reported to be 0.9% (12). However, in 
patients visiting a neurology clinic of the University 
Hospital in Addis Ababa and in commercial sex 
workers in Addis Ababa, the prevalence of HCV 
infection was 6% (11) and 5.3% (12), respectively. 
 
Limited studies done on the magnitude of TTIs 
among blood donors in Ethiopia have shown preva-
lence of HIV to be 4.7% and 16.7% (7, 13), of 
HBsAg 10% (10) and 14.4% (13), and of HCV 1.4% 
(11, 14). The prevalence of TTIs particularly HIV, 
HBV, and HCV among blood donors in other Afri-
can countries is also very high (15, 16). Although 
studies indicating the magnitude of transmission of 
TTIs to blood recipients in Ethiopia are not available, 
considering the lack of national transfusion policy 
and guidelines compounded by the non-reliable sup-
ply of test kits, poor infrastructure and less qualified 
personnel working in the blood banks, the risk of 
acquisition of TTIs through blood transfusion is ex-
pected to be high. 
 
We conducted a cross-sectional study at the Red 
Cross Society Blood Bank in Gondar University hos-
pital with the aims to assess the prevalence of HIV, 
HBV and HCV infection among adult blood donors 
and to investigate risk behaviors in harboring TTIs. 
 
 
METHODS AND MATERIALS  
 
Gondar University Hospital is a teaching and referral 
hospital in Northwest Ethiopia with more than 350 
active beds. The hospital has a Blood “Bank” owned 
by the Ethiopian Red Cross Society. The blood bank 
is run by two technicians and a nurse. Donated 
bloods are regularly tested for HIV, but tests for 
Hepatitis B virus (HBV) and syphilis are done ir-
regularly. At times when there are shortages of sup-
plies like collecting bags, patients are pre-tested for 
HIV before donating blood. Testing of donors for 
HIV is not linked to the VCT in the hospital. 
 
In 2003/2004, blood was collected from 1761 donors. 
About 75% were family replacement and/or remu-
nerated donors. Almost all the donors were first time 
donors. About 13.8% of the donated blood in same 
year was discarded mainly due to TTIs (10.3%). The 
Bank has only five volunteer members who donate 
blood on a regular schedule. 
 
The Blood Bank has an operational manual prepared 
by the National Blood Transfusions Services of the 
Ethiopian Red Cross Society. It uses a Donor Enroll-
ment Form which contains among other things lists 
for identifying donors whose health could be jeop-
ardized following donation of blood. It lacks a com-
prehensive list of risk behaviors or body signs 
which can help identify donors who are potential 
carriers of TTIs.  
 
This study was cross-sectional, and was conducted 
between April and July 2004 at the Ethiopian Red 
Cross Blood Bank in Gondar University Hospital in 
Northwest Ethiopia.  Donors who gave verbal con-
sent to participate in the study were included. A 
questionnaire to collect additional demographic data 
and risk behaviors or factors for TTIs (history of 
transfusion, tattooing, jaundice or close contact with 
jaundiced person, surgical incisions or phlebotomy 
by traditional healers, STI, and multiple sex partners) 
was administered by the technician in the bank. 
Blood collected from all the participating donors was 
tested for the presence of antibodies against HIV 1 & 
2 and HCV, and HBsAg using commercially avail-
able tests ( MicroELISA System Vironstika HIV Uni
-Form II Ag/Ab ( bioMerieux bv, The Netherlands), 
ACON HCV-Test Strip ( ACON Laboratories, inc., 
USA), and Micro ELISA system, Hepanostika 
HBsAg Uni-Form II (bioMerieux bv, The Nether-
lands)). None of the donors returned to know the 
results of the tests performed during this study.  
 
The Gondar University Research and Publications 
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 office has granted the ethical clearance to conduct 
this study in the hospital.  
 
Data are entered and analyzed using Epi Info 2000 
version 3.2.2. Descriptive analysis is done to deter-
mine means and frequencies. Chi square is used to 
compare proportions and odds ratio is used to assess 
risk. Linear and logistic regression analysis are done 
to look for interactions among the various risk be-
haviors and factors.  Significance level is defined as 
probability less than 0.05  
 
 
RESULTS 
The study included 600 adult blood donors of whom 
89.5% were men. The mean age of the donors was 
28.9±10.4 (range 16-64 years). About 66% of the 
donors were urban dwellers. The three major groups 
of donors were farmers (30.7%), daily laborers 
(22.7%), and students (20.7%). (Table-1). About 
75% of the donations during the study period were 
replacement donations either by family members or 
remunerated donors. All were fist time donors. 
 
 
The over all prevalence of TTI was 16.3%. The 
prevalence of HIV, HCV, and HBsAg were 4.5% 
(95%CI: 3-6.6), 5.8% (95%CI: 4.2-8.1), and 8.2% 
(95%CI: 6.2-10.7), respectively. A single TTI was 
detected in 87 (14.5%), dual infection in 9 (1.5%), 
and triple infection in 2 (0.3%) of the donors.  Distri-
bution of HIV was not affected by sex and area of 
residence. However, prevalence of HBsAg was sig-
nificantly higher among rural (12.4%) than urban 
(6%) donors (p=0.006). There was no significant 
difference in distribution of either HBsAg or HCV 
infection by sex and marital status. 
 
More than 93% of the donors had experienced tradi-
tional surgical incisions or phlebotomy. Although 
6.2% of the donors admitted practicing sex with mul-
tiple sexual partners, none of the donors reported a 
history of STI (Table 2). Three of the donors were 
recipients of blood transfusion in the past, and one of 
them has HIV and another one HBsAg. In a univari-
ate analysis no statistical association was established 
between the presence of risk behaviors and/or factors 
and the presence of any of the three TTIs. Four 
HBsAg positive donors and six HCV positive donors 
were co-infected with HIV. There was an association 
between HIV and HCV infection (OR: 5.36, 95%CI: 
2-14.3) but not with HBsAg (Figure 1). 
 
 
Table-1: Socio-demographic characteristics, and prevalence  of TTIs among blood donors at the Red Cross Blood Bank in 
 Gondar University Hospital, Northwest Ethiopia, April-July 2004 
Demographic 
variables N (%)  
All do-
nors 
(N=600)  
HIV 
positive 
(N=27) 
HBsAg 
positive 
(N=49) 
HCV posi-
tive 
(N=35) 
Prevalence No. 16.3% No. 4.5% 8.2% 5.8% 
Age: Mean ±SD 
(range)  
28.9±10.4        
(16-64)  
       
30.8±9.5        
(19-64) 
 30.7± 8.9              
(18-60) 
31±12                 
(18-64) 
Male sex (years) 537 89.5 511 85.2 91.8 88.6 
Residence: Urban 399 66.5 422 70.4 49.0* 54.3 
                    Rural 201 33.5 178 29.6 51.0 45.7 
Marital status           
Single 324 54.0 356 59.3 53.1 45.7 
Married 255 42.5 222 37.0 42.9 54.3 
widowed  20 3.3 23 3.7 4.5 0.0 
divorced    1 0.2 0 0.0 0.0 0.0 
Occupation           
Farmer 184 30.7 178 29.6 44.9 42.9 
Daily laborer 124 20.7 111 18.5 20.4 25.9 
Student 120 20.0 88.8 14.8 10.2 8.6 
Employed   71 11.8 133 22.2 10.2 5.8 
others#  90 14.8 89 14.8 14.3 17.2 
 
No. 
 
551 
294 
306 
 
319 
258 
27 
0 
 
269 
122 
 61 
 61 
86 
 
No. 
 
 
326 
274 
 
274 
326 
0 
0 
 
257 
155 
52 
35 
103 
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Table 2:  Distribution of risk behavior and factors in relation to occurrence of TTIs among blood donors at the Red 
Cross Society Blood Bank in Gondar University Hospital, Northwest Ethiopia, April-July 2004 ( N=600). 
Figure 1: The prevalence of HIV Ab, HBsAg and HCV Ab among blood donors at Red Cross Blood Bank of  
Gondar University Hospital, Northwest Ethiopia, April-July 2004. 
 
Risk Behavior/
factor 
  
All 
(%) 
HIV 
Positive 
(%) 
HBs Ag 
Positive    
(%) 
HCV 
positive 
(%) 
History of 
transfusion 0.5 3.7 2.0 0.0 
History of jaun-
dice 3.3 7.4 2.0 8.6 
His story of 
contact with 
jaundiced per-
son 1.8 0.0 0.0 5.7 
History of STI 0.0 0.0 0.0 0.0 
Multiple Sex-
ual partner 6.2 7.4 6.2 2.9 
Tattooing (non-
fancy) 12.5 14.8 12.2 8.1 
Traditional 
surgical proce-
dures 93.8 96.3 94 91.4 
No 
3 
20 
11 
0 
38 
75 
563 
No 
22 
44 
0 
0 
44 
89 
578 
No. 
12 
12 
0 
0 
37 
73 
564 
No. 
0 
52 
34 
0 
17 
49 
548 
HIV Ab 
(n=27) 
HBsAg 
(n=49) 
HCV Ab 
(n=35) 
19 
26 42 
4 2 
3 
2 
$:  Association between HIV and HCV = OR: 5.36, (95CI: 2-14.3)  
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 Finally, though the blood bank’s manual advises not 
to collect blood from certain group of donors we 
found that blood was collected from individuals with 
history of multiple sexual partners, previous blood 
transfusion recipients, and long distance track driv-
ers.  
 
DISCUSSION 
 
 
This cross-sectional study indicates that more than 
16% of the blood donated was discarded because of 
the presence of any or combined infection with HIV, 
HBsAg and HCV. This figure is comparable to re-
ports from Malawi (17). All cause (infections and 
others) discard rate of donated blood in Ethiopia and 
other developing countries is more than 30% (6, 18). 
In developing countries where the collection of blood 
is very insufficient i.e. less than 30 units per 1000 
population per annum and where discard rate of do-
nated blood is very high, utilizing alternative fluids 
such as crystalloids and colloids, and establishing 
stringent clinical indications for transfusion may be 
preferred options. Using tight donor selection criteria 
would not only help to exclude TTI carriers but also 
would help to economize utilization of infrequently 
available supplies like collecting bags. 
 
The prevalence of HIV among donors in this study is 
4.5% which is comparable to the national prevalence 
of HIV among blood donors in Ethiopia (7) but is 
significantly lower than the 12.8% reported by 
Rahlenbeck S et al (13) from the same blood bank in 
1997. The sentinel prevalence study among pregnant 
women in Gondar has not shown a comparable re-
duction in HIV prevalence (7). This apparent reduc-
tion in HIV prevalence could be due to difference in 
the composition of donors or self-deferral from dona-
tion due to awareness of ones risk behaviors to HIV. 
While there are no soldiers in the current study, sol-
diers were important donors in the previous study in 
whom HIV prevalence was up to 30%. Though our 
study was conducted in a relatively short period, it 
may indicate a change in trend of selection of donors 
i.e. deferral of donors from some group of individu-
als like soldiers, contributing to the apparent decline 
in HIV rate among donors. Studies have indicated 
that introduction of pre-donation deferral policies of 
donors from groups of individuals or institutions who 
are at a high risk of harboring TTIs has significantly 
decreased risk of transmission of TTIs (19). 
 
HBsAg was detected in about 8.2% of the donors 
which is lower than previously reported rate of 
14.4% (13) from the same Blood Bank but it is simi-
lar to figures reported from Addis Ababa (8.2%). In 
agreement with the previous report from the same 
site (13), HBsAg was more prevalent among rural 
residents. The mechanisms of transmission of Hepa-
titis B virus among the populations in developing 
countries have been unsettled issue. Studies have 
indicated that there is a possibility of horizontal 
transmission of HBV among crowded family mem-
bers (21) ,and vertical or perinatal transmission HBV 
among Ethiopian population is not common (22). 
More than 60% of the population in Ethiopia has one 
or more markers of HBV infection, and hence some 
authorities previously had recommended that routine 
screening of blood for HBsAg may not be cost-
effective and not warranted (10). Despite this how-
ever, WHO (1) and many other studies from Africa 
recommended the routine screening of donated blood 
for HBsAg (15-17). 
 
The prevalence of HCV in the general population in 
Ethiopia is not well investigated. A survey conducted 
in 1993 found a prevalence of 2% in the community 
(11). The prevalence of HCV in the current study is 
5.8% which is higher than the rate in the general 
population. This figure is, however, comparable to 
the 6% prevalence among patients attending Neurol-
ogy Clinic in Addis Ababa (11) and to the 5.3 preva-
lence among commercial sex workers in Addis 
Ababa (12). It is, therefore, possible that the donors 
of the current study may exhibit similar risk behav-
iors for acquisition of HCV Furthermore, presence of 
HCV in the donors was associated with the HIV 
seropositivity. This association has been documented 
in a community survey in Addis Ababa (12). The 
association could be due to shared risk factors for 
both infections (12, 23). However, it is also surmised 
that HIV may increase the susceptibility for HCV 
infection through unknown mechanisms (23). 
 
The majority of the blood donations were replace-
ment and first time donations from family members 
and/ or remunerated donors. It is well known that 
replacement and first-time donors have higher preva-
lence of TTIs than voluntary non-remunerated do-
nors (1, 25). In countries where prevalence of TTIs in 
the general population is high, low risk donors can be 
recruited by implementing stringent donor selection 
criteria. A Model Transfusion Services in Zimbabwe 
selection of donors with HIV prevalence as low as 
0.7% and 2.3% in regular donors and new blood do-
nors, respectively, was achieved compared to HIV 
prevalence of 25.8% in the general adult population 
(1). The introduction of behavioral risk factor screen-
ing among potential donors has made a significant 
contribution to progressive reduction in the incidence 
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 and prevalence of TTIs in donors in developed coun-
tries (26).  
 
There is a need of refresher training for the techni-
cians so that the recommendations on the blood bank 
manual are adhered to. More over, the donor enroll-
ment form needs to be updated to include more ex-
clusion criteria with clear guidance on inclusion and 
exclusion criteria. 
 
In conclusion, very high rate of TTIs among blood 
donors was found. The majority of blood was col-
lected from replacement donations, first time and 
remunerated donors. These made blood transfusion 
unsafe. These showed the urgent need to introduce 
safe blood transfusion services. While assuring safety 
of blood transfusion using high technology screening 
 
 
 
 
methods and qualified personnel are not in the imme-
diate scope, establishing and implementing rigorous 
donor selection criteria, providing refresher training 
to personnel working in Blood Banks, improving 
availability of alternative fluids like crystalloids and 
colloids, and controlling liberal transfusion of blood 
to patients are cost effective and proven ways of de-
creasing risk of transmission of infections to blood 
recipients. 
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